
	Chemical structure search How to Search	Import MOLfile format is only available (V3000 format is not available) Exact match Substructure search Superstructure search Substructure or superstructure search Similarity search

Details
Related links
Search

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr

J-GLOBAL ID：201301042735235430 Update date: Feb. 03, 2025

Ohishi Tomokazu

オオイシトモカヅ | Ohishi Tomokazu

Clips

Affiliation and department：
Job title： Senior Researcher
Homepage URL (1)： http://kaken.nii.ac.jp/d/r/50442546.ja.html

Research field (4)： Tumor biology , Pharmaceuticals - chemistry and drug development , Tumor diagnostics and therapeutics , Laboratory animal science

Research keywords (15)： Red blood cells , Phospholipid remodeling , bacteriology , microbiology , Monoclonal antibody , Cancer metastasis , Tea , PARP , Poly(ADP-ribosyl)ation , Tankyrase , Cancer , Tmour , Molecular targeted therapy , Chemical biology , Tumor-stromal cell interactions

Research theme for competitive and other funds (12)：

2024 - 2029 Development of cancer-specific antibodies for clinical application using CasMab technology
2022 - 2025 Establishment of Therapeutic Strategies Targeting Stromal-Derived Factor PAI-1, Which Determines Liver Metastasis in Colorectal Cancer
2023 - 2024 Exploration of Novel Drug Seeds Using Secondary Metabolites from Cordyceps Fungus and Mouse Tumor Models
2021 - 2024 Development of Advanced Cancer-Specific Antibody Creation Technologies and Their Medical Applications Targeting Refractory Cancers (Principal Investigator: Yukinari Kato)
2022 - 2023 Elucidation of the Significance of Cancer Cell Membrane Phospholipid Remodeling by Lysophosphatidylcholine Acyltransferase 1 (LPCAT1)

Show all

Papers (104)：

Mika K. Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Miyuki Yanaka, Tomohiro Tanaka, Yukinari Kato. Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH₂Mab-250 in Human Breast Cancer Xenografts. International Journal of Molecular Sciences. 2025
Tomohiro Tanaka, Hiroyuki Suzuki, Tomokazu Ohishi, Mika K. Kaneko, Yukinari Kato. A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG_2a Exerts Antitumor Activities in Human Tumor Xenograft Models. Cells. 2024
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Miyuki Yanaka, Guanjie Li, Tomohiro Tanaka, Akira Ohkoshi, Manabu Kawada, Mika Kaneko, et al. Antitumor activities of anti-CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer. Oncology Reports. 2024. 52. 5
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Guanjie Li, Tomohiro Tanaka, Manabu Kawada, Akira Ohkoshi, Mika K. Kaneko, Yukio Katori, Yukinari Kato. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas. International Journal of Molecular Sciences. 2024. 25. 17. 9190-9190
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato. Anti-HER2 Cancer-Specific mAb, H2Mab-250-hG1, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. International journal of molecular sciences. 2024. 25. 15

ｍore...

MISC (86)：

Junjiro Yoshida, Tomokazu Ohishi, Manabu Kawada. Drug Discovery Targeting Cancer Energy Metabolism Using Inhibitors of Metabolic Enzymes. Clinical Oncology, edited by the Editorial Committee of Clinical Oncology. 2023. 31. 1. 102-108
Asano Teizo, Ohishi Tomokazu, Suzuki Hiroyuki, Kawada Manabu, Kaneko Mika K., Kato Yukinari. Antitumor activity of a novel anti-HER3 monoclonal antibody in mouse xenografts of colorectal cancer. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2022. 95. 2-O-056
Takei Junko, K. Kaneko Mika, Ohishi Tomokazu, Asano Teizo, Kawada Manabu, Harada Hiroyuki, Kato Yukinari. Development of a monoclonal antibody for CD44-expressing oral cancers. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2021. 94. 2-O-D1-4
Tomokazu Ohishi, Junjiro Yoshida, Manabu Kawada. The existing state of drug development targetting the tumor-stromal cell interactions. Experimental medicine. 2021. 39. 12
Tomokazu Ohishi, Manabu Kawada. Involvement of the fibrinolytic system regulator in the liver metastasis of colorectal cancer. Abstracts of the Japanese Cancer Association Annual Meeting. 2021. 30th

ｍore...

Books (5)：

CLINICAL ONCOLOGY(Jan./2023), Drug discovery targeting cancer energy metabolism
Kagaku Hyoronsha 2023
Experimental Medicine (Vol.39 No.12) Tackling the Cancer Microenvironment at the Single-Cell Level
Yodosha 2021
Microbes and Immunity
Kenpakusha 2020
Molecular Target Therapy of Cancer, Cancer treatment targeting telomeres and telomerase
Nanzando 2008 ISBN:9784525420413
The CELL, October 2007 Issue, Regulation of the spindle by Aurora kinases
New Science Company 2007

Lectures and oral presentations (7)：

Establishment and Research of an In Vivo Screening System for Anticancer Drugs Using Cordyceps Culture Fluid
(2023)
The Role and Regulation of Cancer-Stroma Interaction in Liver Metastasis of Colorectal Cancer
(32nd Annual Meeting of the Japanese Association for Metastasis Research, Symposium “Cutting-Edge Biopharmaceutical Development Techniques to Conquer Cancer Metastasis 2023)
Understanding the Components and Health Functions of Tea
(Open Seminar by NPO China Tea Culture Association 2023)
New Potential Health Benefits of Tea: COVID-19, Cancer, and Lifestyle-Related Diseases
(Open Symposium on the Power of Tea in the With-COVID Era 2023)
New Potential Functions of Polyphenols
(2022)

ｍore...

Education (1)：

2002 - 2006 The University of Tokyo Graduate School of Medicine

Professional career (1)：

Doctor of Medicine (Ph.D.) (The University of Tokyo)

Work history (4)：

2022/04 - 現在 Institute of Microbial Chemistry(BIKAKEN), Microbial Chemistry Research Foundation Laboratory of Oncology, Numazu brunch
2015/04 - 2022/03 Institute of Microbial Chemistry(BIKAKEN), Microbial Chemistry Research Foundation Numazu branch
2014/04 - 2015/03 Tokyo Metropolitan Institute of Medical Science
2006/04 - 2014/03 Japanese Foundation for Cancer Research

Committee career (5)：

2024/09 - 現在 The Japanese Cancer Association Councilor
2024/05 - 現在 Public Relations Committee Working Group Japanese Cancer Association
2018/04 - 現在 International Symposium on Cancer Chemotherapy Committee member
2017/04 - 現在 Japanese Association for Molecular Target Therapy of Cancer Councilor
2022/01 - 2023/01 Secretariat of the 32nd New Drug Discovery Meeting

Awards (7)：

2021/05 - The Japanese Association for Molecular Target Therapy of Cancer Excellent Presentation Award
2020/01 - 20th Kanto Hormone and Cancer Research Group
2017/03 - Cosmo Bio Co., LTD. Cosmo Bio Award
2016/12 - The Japanese Society of Clinical Pharmacology and Therapeutics Excellent Presentation Award
2016/06 - The Japanese Association for Molecular Target Therapy of Cancer Research Encouragement Award

Show all

Association Membership(s) (5)：

The Japanese Association for Metastasis Research , International Symposium on Cancer Chemotherapy , The Japanese Association for Molecular Target Therapy of Cancer , Japanese Cancer Association , The Japanese Society of Clinical Pharmacology and Therapeutics

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page


	Free word	※Add the following synonyms, you can increase the number of hits.




		～